These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 96250)

  • 1. Hemodynamic effects of systemic and central administration of alpha-methyldopa.
    Forsyth RP; Bolme P; Ishizaki T; Melmon KL
    J Pharmacol Exp Ther; 1978 Jun; 205(3):675-82. PubMed ID: 96250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of central and peripheral mechanisms in the action of alpha-methyldopa on blood pressure and renin secretion.
    Frankel RJ; Reid IA; Ganong WF
    J Pharmacol Exp Ther; 1977 May; 201(2):400-5. PubMed ID: 323462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological effects of alpha-methyldopa, alpha-methylnorepinephrine, and octopamine on rat arteriolar, arterial, and terminal vascular smooth.
    Altura BM
    Circ Res; 1975 Jun; 36(6 Suppl 1):233-40. PubMed ID: 1093755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic, pulmonary and coronary haemodynamic actions of the novel dopamine receptor agonist in awake pigs at rest and during treadmill exercise Z1046.
    Duncker DJ; Haitsma DB; van der Geest IE; Stubenitsky R; van Meegen JR; Man in't Veld AJ; Verdouw PD
    Br J Pharmacol; 1997 Mar; 120(6):1101-13. PubMed ID: 9134223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proceedings: Possible mechanism of action of methyldopa: relationship studies between route on administration, dose, plasma concentration and hemodynamic changes in conscious monkeys.
    Ishizaki T; Forsyth RP; Melmon KL
    Jpn J Pharmacol; 1974; 24(0):s:119. PubMed ID: 4209044
    [No Abstract]   [Full Text] [Related]  

  • 6. Central hypotensive action of alpha-methyldopa: an iontophoretic study in the cat.
    Sharma JN; Sandrew BB; Wang SC
    Arch Int Pharmacodyn Ther; 1979 Sep; 241(1):92-9. PubMed ID: 526073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic disposition and cardiovascular effects of methyldopate in unanesthetized rhesus monkeys.
    Walson PD; Marshall KS; Forsyth RP; Rapoport R; Melmon KL; Castagnoli N
    J Pharmacol Exp Ther; 1975 Oct; 195(1):151-8. PubMed ID: 810574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the mechanism of the cardiovascualr effects of methyldopa.
    Lokhandwala MF; Buckley JP; Jandhyala BS
    Eur J Pharmacol; 1976 May; 37(1):79-89. PubMed ID: 6292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular effects of intracerebroventricularly injected CDP-choline in normotensive and hypotensive animals: the involvement of cholinergic system.
    Savci V; Cavun S; Goktalay G; Ulus IH
    Naunyn Schmiedebergs Arch Pharmacol; 2002 May; 365(5):388-98. PubMed ID: 12012025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodynimic effects of systemic and central administration of clonidine in the monkey.
    Bolme P; Forsyth RP; Ishizaki T; Melmon KL
    Am J Physiol; 1975 Apr; 228(4):1276-9. PubMed ID: 1130526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular effects of rat calcitonin gene-related peptide in the conscious rat.
    Sirén AL; Feuerstein G
    J Pharmacol Exp Ther; 1988 Oct; 247(1):69-78. PubMed ID: 2459371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
    Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
    Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primate cardiovascular responses mediated by dopamine receptors: effects of N,N-di-n-propyldopamine and LY171555.
    Hahn RA; MacDonald BR
    J Pharmacol Exp Ther; 1984 Apr; 229(1):132-8. PubMed ID: 6707929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central and peripheral cardiovascular effects of alpha-methylepinephrine.
    Tung CS; Goldberg MR; Hollister AS; Oates JA; Robertson D
    J Pharmacol Exp Ther; 1983 Nov; 227(2):484-90. PubMed ID: 6355433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypotensive activity of S-alpha-methyldopa during long-term (steady-state) intravenous infusions.
    Walson PD; Pesout J; Forsyth RP; Castagnoli N; Melmon KL
    J Pharmacokinet Biopharm; 1976 Oct; 4(5):389-94. PubMed ID: 826619
    [No Abstract]   [Full Text] [Related]  

  • 16. Vasopressin: mechanism of central cardiovascular action in conscious rats.
    Rohmeiss P; Becker H; Dietrich R; Luft F; Unger T
    J Cardiovasc Pharmacol; 1986; 8(4):689-96. PubMed ID: 2427805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unusual alpha adrenergic receptor potency of methyldopa metabolites on melanocyte function.
    Pettinger WA
    J Pharmacol Exp Ther; 1977 Jun; 201(3):622-6. PubMed ID: 16998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of the tachycardia following systemic alpha-methyldopa administration in conscious rats.
    van der Maas ML; Head GA; de Jong W
    J Cardiovasc Pharmacol; 1986; 8(5):1014-9. PubMed ID: 2429074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological, hemodynamic and biochemical mechanisms involved in the blood pressure lowering effects of pergolide, in normotensive and hypertensive dogs.
    Cavero I; Lorrain J; Di Paola ED; Lhoste F; Payen B; Dennis T; Scatton B
    J Pharmacol Exp Ther; 1985 Dec; 235(3):798-809. PubMed ID: 2934543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central cardiovascular effects of clonidine and another imidazoline derivative ST [600] in adult fowls.
    Marmo E; Nisticò G; Rossi F; Rotiroti D
    Res Commun Chem Pathol Pharmacol; 1978 Jan; 19(1):1-10. PubMed ID: 625578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.